Media Releases Archive - Insphero
Nov 03, 2016

November 03, 2016 – InSphero Scientist Receives 3Rs Award for Microtissue-based Body on a Chip System

InSphero Scientist Receives 3Rs Award for Microtissue-based Body on a Chip System Dr. Olivier Frey honored by IQ Consortium and AAALAC International for work on microphysiological system to reduce animal-based […]

Read More
 
 
Oct 20, 2016

October 20, 2016 – 3D Cell Culture Experts Assemble for Inaugural New Frontiers in 3D Conference

3D Cell Culture Experts Assemble for Inaugural New Frontiers in 3D Conference Event draws over 100 leading government, industry, and academic leaders to further translational applications of 3D tissue models. […]

Read More
 
 
Sep 21, 2016

September 21, 2016 – InSphero, US Congressional Leaders Discuss Technologies to Reduce Animal Research

InSphero, US Congressional Leaders Discuss Technologies to Reduce Animal Research US legislators and InSphero experts discuss benefits of human-derived 3D microtissues for more efficient drug development and less animal testing. […]

Read More
 
 
Sep 07, 2016

September 07, 2016 – InSphero Launches 3D Mitochondrial Toxicity Testing Service

InSphero Launches 3D Mitochondrial Toxicity Testing Service New contract screening offering combines advanced 3D liver microtissue models and Agilent XFe96 Analyzer to identify mitochondrial liabilities for drug safety testing market. […]

Read More
 
 
Jul 13, 2016

July 13, 2016 – Registration Open for New Frontiers in 3D Cell Culture-based Screening Technologies Conference

Registration Open for New Frontiers in 3D Cell Culture-based Screening Technologies Conference Schlieren, Switzerland, July 13, 2016 – Inaugural meeting, organized by InSphero AG, NCATS, CAAT, and Promega Corp., to […]

Read More
 
 
Jul 11, 2016

July 11, 2016 – InvitroCue Commences Pancreatic Toxicity Assay Development

InvitroCue Commences Pancreatic Toxicity Assay Development 11 July 2016 – InvitroCue (ASX:IVQ), a leader in advanced bio-analytics, has progressed its technology in modelling multi-organ toxicity by developing a novel assay […]

Read More
 
 
Jun 16, 2016

June 16, 2016 – Nature Scientific Reports Article Touts Versatility, Promise of 3D Human Liver Microtissues for Drug Development

Nature Scientific Reports Article Touts Versatility, Promise of 3D Human Liver Microtissues for Drug Development Schlieren, Switzerland, June 16, 2016 – Liver spheroids display longer culture lifetime, liver-like functionality, and […]

Read More
 
 
Mar 16, 2016

March 16, 2016 – InSphero Launches Multi-donor Human Liver Microtissues for Prediction of Drug-induced Liver Injury

InSphero Launches Multi-donor Human Liver Microtissues for Prediction of Drug-induced Liver Injury Schlieren, Switzerland, March 16, 2016 – 3D human liver microtissues comprised of pooled hepatocytes from multiple donors offers […]

Read More
 
 
Feb 10, 2016

February 10, 2016 – InSphero Contributes 3D Microtissue-based Assay Chapter to NCATS/NIH Assay Guidance Manual

InSphero Contributes 3D Microtissue-based Assay Chapter to NCATS/NIH Assay Guidance Manual Schlieren, Switzerland, February 10, 2016 – Latest update of industry manual for development of high-throughput screening calls on scientists […]

Read More
 
 
Feb 01, 2016

February 01, 2016 – InSphero Inc. Streamlines 3D Microtissue Business Operations in US

InSphero Inc. Streamlines 3D Microtissue Business Operations in US Schlieren, Switzerland, February 01, 2016 – US subsidiary of Swiss-based InSphero AG initiates direct product shipments, progresses towards full-scale US bioproduction […]

Read More
 
 
Page 1 of 41234